Search
for
Sort by
Research 271–300 of 1000+
- Mesenchymal Stem Cell Therapy in Alopecia Areata: Visual and Molecular Evidence from a Mouse Model
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Pharmacotherapy for Keloids and Hypertrophic Scars
- Non‐biologic immunosuppressive drugs for inflammatory and autoimmune skin diseases
- Effects of oleanolic acid on hair growth in mouse dorsal skin mediated via regulation of inflammatory cytokines
- Commonly associated disorders with complete scalp alopecia in early childhood: A review
- The spectrum of fibrosing alopecias
- Drug Armamentarium for alopecia areata
- Vitiligo and alopecia areata: apples and oranges?
- Three Cases of Alopecia Following Clinical Islet Transplantation
- Tofacitinib Loaded Squalenyl Nanoparticles for Targeted Follicular Delivery in Inflammatory Skin Diseases
- Enhanced Skin Permeation and Controlled Release of β-Sitosterol Using Cubosomes Encrusted with Dissolving Microneedles for the Management of Alopecia
- Recent Understandings of Biology, Prophylaxis and Treatment Strategies for Hypertrophic Scars and Keloids
- Alopecia Areata: an Update on Etiopathogenesis, Diagnosis, and Management
- Lymphocytes, neuropeptides, and genes involved in alopecia areata
- Mucocutaneous reactions to chemotherapy
- Zinc Therapy in Dermatology: A Review
- Skin Pigmentation Types, Causes and Treatment—A Review
- A phase 2a randomized, placebo-controlled study to evaluate the efficacy and safety of the oral Janus kinase inhibitors ritlecitinib and brepocitinib in alopecia areata: 24-week results
- Cell death in the skin
- Overview of Alopecia Areata
- Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases
- Microneedles as transdermal drug delivery system for enhancing skin disease treatment
- Alopecia Areata: An Updated Review for 2023
- The genetics of alopecia areata: New approaches, new findings, new treatments
- Dissolving microneedles: Applications and growing therapeutic potential
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Alopecia Areata: Current Treatments and New Directions
- Alopecia areata: What’s new in epidemiology, pathogenesis, diagnosis, and therapeutic options?
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata